Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Taste receptor type 2 (T2R) family is a group of G protein-coupled receptors (GPCRs) that traditionally mediate bitter taste perception in humans. While initially identified in taste buds, these receptors are now known to be expressed in diverse extra-oral tissues, including the lungs, gastrointestinal tract, and immune cells, where they function as critical chemosensors. In the respiratory system, T2R activation leads to smooth muscle relaxation and increased ciliary clearance, offering a novel pathway for treating asthma and chronic obstructive pulmonary disease. In the gut, they modulate the secretion of hunger-regulating hormones like GLP-1 and CCK, indicating a role in metabolic regulation. Additionally, T2Rs contribute to innate immunity by detecting bacterial signaling molecules and triggering the release of nitric oxide and antimicrobial peptides. The significant genetic diversity within the T2R family, particularly the TAS2R38 polymorphism, influences individual responses to bitter compounds and potentially impacts disease susceptibility and drug efficacy. Pharmacological targeting of T2Rs is an emerging area of interest, with agonists like chloroquine and quinine being explored for their non-canonical effects in non-gustatory tissues. However, the widespread expression of these receptors poses challenges for achieving tissue-specific therapeutic effects without off-target consequences.
Agonism of T2R receptors leads to the activation of heterotrimeric G proteins (typically gustducin or Gq/11), which stimulates phospholipase C beta-2 (PLC-β2), resulting in the release of intracellular calcium and subsequent downstream signaling pathways such as bronchodilation, hormone secretion, or activation of nitric oxide synthase (NOS) in airway epithelial cells.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 family (T2R) (T2R).